NVAX Novavax Inc.

-0.01  -2%
Previous Close 0.53
Open 0.52
Price To Book -1.45
Market Cap 244867145
Shares 469,453,883
Volume 8,867,683
Short Ratio
Av. Daily Volume 19,027,599

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 immunogenicity and safety data data released January 3, 2019. Phase 3 trial to be initiated in 2019.
NanoFlu vaccine
Phase 2 safety and immunogenicity data released July 24, 2017 - efficacy trial to be initiated 2018.
RSV F Vaccine immunogenicity trial
Respiratory Syncytial Virus (RSV) in older adults
Phase 3 released September 15, 2016 did not demonstrate efficacy.
RSV vaccine - Resolve trial
Respiratory Syncytial Virus (RSV) in older adults
Phase 2 data released September 15, 2016.
RSV F Vaccine rollover trial
Respiratory Syncytial Virus (RSV) in older adults
Phase 3 top-line data released March 28, 2019 - primary endpoint not met.
RSV vaccine - prepare trial
Respiratory Syncytial Virus (RSV) in healthy pregnant women - protect infants via maternal immunization
Further Phase 2 trials planned
Seasonal Influenza Vaccine
Seasonal Flu

Latest News

  1. The Daily Biotech Pulse: J&J Earnings, FDA Nod For Medicinova, Proteon To Explore Strategic Alternatives
  2. Novavax faces delisting threat following failed drug trial
  3. The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
  4. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Novavax, Inc.
  5. Novavax (NVAX) Stock Moves -0.67%: What You Should Know
  6. Novavax Scientific Leadership to Present RSV Maternal Immunization Program Phase 3 Data and Participate in Panel on COPD at World Vaccine Congress
  7. Edited Transcript of NVAX earnings conference call or presentation 18-Mar-19 8:30pm GMT
  8. Novavax (NVAX) Outpaces Stock Market Gains: What You Should Know
  9. Novavax (NVAX) Gains As Market Dips: What You Should Know
  10. Four Healthcare Stocks Picking Up Speed on Wednesday
  11. 3 Cheap Stocks to Buy That Are Worth Every Penny
  12. Do Options Traders Know Something About Novavax (NVAX) Stock We Don't?
  13. Why Novavax Is Soaring Today
  14. Does Novavax Have a Viable Path Forward?
  15. What's Next for Novavax?
  16. Novavax (NVAX) Q4 2018 Earnings Conference Call Transcript
  17. Novavax: 4Q Earnings Snapshot
  18. Novavax Reports Fourth Quarter and Year-End 2018 Financial Results
  19. The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
  20. These Four Healthcare Stocks Are Making Moves on Wednesday